Gene Silencing News and Research

RSS
Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Trends, R&D progress, and predicted revenues in RNAi therapies

Trends, R&D progress, and predicted revenues in RNAi therapies

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans

Vital molecular mechanism in plants has similarities to certain signaling mechanisms in humans

Adaptimmune’s NY-ESO-1 TCR-engineered T-cell therapy mediates sustained antitumor effects in multiple myeloma patients

Adaptimmune’s NY-ESO-1 TCR-engineered T-cell therapy mediates sustained antitumor effects in multiple myeloma patients

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

New understanding of how Huntington's disease gene works

New understanding of how Huntington's disease gene works

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Scientists identify small RNA molecule that can suppress cancer-causing genes in GBM

Rigontec raises €4.8 million in second closing of Series A financing round

Rigontec raises €4.8 million in second closing of Series A financing round

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Fourth patient dosed in Benitec Biopharma's Phase I/IIa hepatitis C trial

Combination therapies may overcome resistance to targeted cancer drugs

Combination therapies may overcome resistance to targeted cancer drugs

Parents can pass silenced genes to offspring through a specific mechanism

Parents can pass silenced genes to offspring through a specific mechanism

Phase IIb trial shows platinum-resistant ovarian patients treated with PM1183 live longer

Phase IIb trial shows platinum-resistant ovarian patients treated with PM1183 live longer

TET1 enzyme may be important target for cancer diagnostics, treatment

TET1 enzyme may be important target for cancer diagnostics, treatment

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Researchers discover a new way to combat influenza virus infection

Researchers discover a new way to combat influenza virus infection

Promising new approach for combating colorectal cancer

Promising new approach for combating colorectal cancer

Internal production of hydrogen peroxide can lead cells to exit cell cycle and become senescent

Internal production of hydrogen peroxide can lead cells to exit cell cycle and become senescent